Third-Line Treatment Options for mCRC

preview_player
Показать описание
In this segment, the panelists discuss third-line treatment of metastatic colorectal cancer.

  1. OncLive
  2. cancer
  3. oncology
  4. Colorectal Cancer (Disease Or Medical Condition)
  5. Cancer (Disease Or Medical Condition)
  6. Colon Cancer
Рекомендации по теме
Third-Line Treatment Options 0:05:02

Third-Line Treatment Options for mCRC

Treatment Options for 0:07:35

Treatment Options for Third-Line Therapy in mCRC

mCRC: Options for 0:05:03

mCRC: Options for Third-Line Therapy

mCRC: Options for 0:03:30

mCRC: Options for Third-Line Therapy and Beyond

Options for Third-line 0:05:55

Options for Third-line Therapy in Metastatic CRC

Treatment optimisation in 0:31:13

Treatment optimisation in mCRC: third line and beyond

Third-Line Therapy for 0:05:52

Third-Line Therapy for Metastatic Colon Cancer

Toxicity Management for 0:05:03

Toxicity Management for Third-line Therapy for mCRC

Third-Line Treatment in 0:06:04

Third-Line Treatment in Refractory CRC

Management of Adverse 0:15:47

Management of Adverse Events Associated with Third-line mCRC Treatments

Third-Line Therapy for 0:08:39

Third-Line Therapy for Metastatic Colorectal Cancer

Case 3: Third-Line 0:04:08

Case 3: Third-Line Therapy for Metastatic CRC

mCRC: Third-Line Treatment 0:03:11

mCRC: Third-Line Treatment Decisions

39 Third Line 0:27:56

39 Third Line Therapy & Higher

Third-line and Later-line 0:03:20

Third-line and Later-line Therapies in R/R mCRC

Treatment Options in 0:07:32

Treatment Options in Refractory mCRC

Emerging Treatment Options 0:18:55

Emerging Treatment Options for mCRC Patients in the Late-line Setting

Salvage Therapy Options 0:07:15

Salvage Therapy Options for mCRC

Setting Expectations in 0:07:02

Setting Expectations in Third-Line Colorectal Cancer

Therapy in the 0:07:43

Therapy in the Salvage Setting of mCRC

Case Discussion: Individualized 0:11:54

Case Discussion: Individualized Selection and Sequencing in the Next-Line Treatment of mCRC

Controversy Debate 4: 0:19:52

Controversy Debate 4: Treatment algorithms in metastatic CRC - ESMO guidelines

Treatment Goals in 0:03:04

Treatment Goals in Refractory mCRC

Later-Line Treatment for 0:02:13

Later-Line Treatment for mCRC: Regorafenib or TAS-102?

welcome to shbcf.ru